vTv Therapeutics Inc. (VTVT) Short Interest
Nasdaq • VTVT • US9183852048
As of Oct 27, 2026, ORTEX estimated 9.7% of free float sold short, 6.8 days to cover, cost to borrow 4.07%. Sign up for live short interest data.
Nasdaq • VTVT • US9183852048
As of Oct 27, 2026, ORTEX estimated 9.7% of free float sold short, 6.8 days to cover, cost to borrow 4.07%. Sign up for live short interest data.
This page tracks how heavily vTv Therapeutics Inc. (Nasdaq:VTVT) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
vTv Therapeutics Inc. (Nasdaq: VTVT) has a market capitalization of $266.76M. Last close $21.47 (as of 2026-11-12); 52-week range $20.56 to $44.00. ORTEX data as of 2026-10-27: short interest was 9.73% of free float, 6.8 days to cover and the average cost to borrow was 4.07%. Sign up for live short interest data.